<Research>BOCOMI: Trump's New Tariffs on Imported Innovative Medications Likely to Have Minimal Effect on Chinese Pharmaceutical Companies
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 26 2025
0mins
Source: aastocks
Tariff Announcement: US President Donald Trump will impose a 100% tariff on imported branded or patented finished drugs starting in October, unless manufacturers establish production facilities in the US; generic drugs and certain intermediates will be exempt.
Impact on Chinese Drug Companies: The tariff's effect on China's innovative drug sector is expected to be minimal, as few companies export directly to the US, with many having production capabilities in the US or using local contract manufacturers.
Analyst Views on 00013
Wall Street analysts forecast 00013 stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for 00013 is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 23.420
Low
Averages
High
Current: 23.420
Low
Averages
High
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
